BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
Advancing targeted delivery of intracellular protein therapeutics
Advancing targeted delivery of intracellular protein therapeutics is a funding opportunity from BOSTON UNIVERSITY (CHARLES RIVER CAMPUS), up to 449625, closing December 31, 2030.
Dec 31, 2030
(1614d left)Overview
PROJECT SUMMARY Intracellular protein delivery has immense potential for research and therapeutic applications, from replacing dysfunctional proteins to modulating key signaling pathways and safely delivering genome editing modalities. However, efficiently delivering functional proteins into the cell cytosol remains a…